ALGN

Align Technology, Inc.

Fundamental data last updated:June 5, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Healthcare

industry

Medical - Devices

Exchange

NASDAQ

County of HQ

US

Next Earnings Date

07/29/2026

Business Summary

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

 


VALUATION

P/E

29.45

Market Cap ($M USD)

$12.70B

Forward P/E

11.24

PEG

0.07

PRICE TO SALES

3.10

PRICE TO BOOK

3.05

EV / EBITDA

14.52

5-Year Average P/E

Free Cash Flow Yield

5.40%

DCF Value

$88.07

Graham Number

$88.70

Price to FCF

18.50

EV to FCF

17.08

Earnings Yield

3.40%

FCF Yield

5.40%

DIVIDEND

Yield

0.00%

Annual Payout

$0.00

Payout Ratio

0.00%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$6.02

Next Year EPS Growth Estimate

$15.77

Next Year Revenue Growth Estimate

$489.00B

Return on Equity (ROE)

10.70%

FREE CASH FLOW

Operating Margin

14.44%

Debt-to-Equity

0.03

Piotroski F-Score

8

Altman Z-Score

4.90

Return on Invested Capital (ROIC)

13.42%

Current Ratio

1.39

Quick Ratio

1.28

Net Debt to EBITDA

-1.21

Interest Coverage

378.26

Gross Profit margin

67.68%

FCF PER SHARE

$9.61

REVENUE PER SHARE

$57.34

Gainseekers Quantitative Analysis

Summary

Align Technology’s valuation presents a compelling dichotomy. Despite trading below its DCF value and Graham Number, the market’s forward-looking optimism is evident in a Forward P/E of 10.70, suggesting expectations of robust earnings growth. The Altman Z-score of 5.02 indicates financial stability, while the Earnings Yield of 3.57% reflects moderate income generation relative to price. The stock’s current pricing suggests a potential undervaluation, especially given its strong growth prospects.

AI Exposure / Tech Reliance

Operating in the Medical Devices industry, Align Technology is well-positioned to leverage AI advancements in healthcare. The company's focus on innovative orthodontic solutions aligns with tech-driven shifts, enhancing its adaptability. This strategic positioning could bolster its competitive edge in a rapidly evolving market.

The Bull Case

For value and GARP investors, Align Technology offers a tantalizing proposition. With an impressive ROIC of 13.42% and a Piotroski F-Score of 8, the company demonstrates efficient capital allocation and strong financial health. Its Free Cash Flow Yield, though modest, underscores a capacity for reinvestment and growth. The robust operating margin of 14.44% highlights pricing power, suggesting a resilient business model capable of sustaining profitability.

The Bear Case

However, the stock is not without its flaws. The Price/Sales ratio of 2.95 and Price/Book ratio of 2.91 indicate a premium valuation, potentially limiting upside. The stock's proximity to its 52-week high, with a mere 23.42% distance, suggests technical overextension. Additionally, the zero dividend yield may deter income-focused investors, highlighting a potential gap in shareholder returns.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$203.60

Institutional Ownership %

1-Year Beta

1.70

Insider Buying % (6 Mo)

Distance to 52-Week High

17.51%

Distance to 52-Week Low

31.18%

EARNINGS SURPRISE %

14.16%

50-DAY SMA

$174.02

200-DAY SMA

$157.92

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.